+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1663 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1036 Pages
  • Global
From
Melanoma Therapeutics: Global Markets - Product Thumbnail Image

Melanoma Therapeutics: Global Markets

  • Report
  • November 2023
  • 131 Pages
  • Global
From
Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • December 2024
  • 438 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 814 Pages
  • Global
From
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Biobetters - Global Strategic Business Report - Product Thumbnail Image

Biobetters - Global Strategic Business Report

  • Report
  • July 2025
  • 488 Pages
  • Global
From
Asthma Therapeutics Market by Product Type, Drug Class, Distribution Channel, Route Of Administration, End User - Global Forecast to 2030 - Product Thumbnail Image

Asthma Therapeutics Market by Product Type, Drug Class, Distribution Channel, Route Of Administration, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 184 Pages
  • Global
From
Colorectal Cancer Drugs Market by Drug Class, Distribution Channel, Route Of Administration, Line Of Therapy, Target Molecule, Treatment Setting - Global Forecast to 2030 - Product Thumbnail Image

Colorectal Cancer Drugs Market by Drug Class, Distribution Channel, Route Of Administration, Line Of Therapy, Target Molecule, Treatment Setting - Global Forecast to 2030

  • Report
  • May 2025
  • 198 Pages
  • Global
From
Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033 - Product Thumbnail Image

Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033

  • Report
  • December 2023
  • 134 Pages
  • Global
From
Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 180 Pages
  • Global
From
Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 136 Pages
  • Global
From
Inhalable Drugs - Global Strategic Business Report - Product Thumbnail Image

Inhalable Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 270 Pages
  • Global
From
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1699 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 175 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Peanut Allergy Treatment Market Size, Share & Trends Analysis Report by Drug Class (Antihistamines, Epinephrine), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report by Drug Class (Antihistamines, Epinephrine), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • December 2023
  • 180 Pages
  • Global
From
Loading Indicator